Falcon Genomics Wins $270K NIH Grant to Develop Breast Cancer Biochip
October 26, 2010
Falcon Genomics Wins $270K NIH Grant to Develop Breast Cancer Biochip
Pittsburgh-based Falcon Genomics has to date marketed its Cancer Biochip System for research purposes. The firm hopes to use the new funds to move the platform into the clinical arena.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Falcon Genomics Showcases Cancer Biochip in Breast Cancer Studies; Plans Next-Gen System
October 2, 2012 / BioArray News - Study Suggests Genetic Susceptibility to T2D May Have Shifted with Human Migration
May 24, 2013 / GenomeWeb Daily News - NIH Team Presents Findings from Fungi-focused Study of Skin Microbiome
May 22, 2013 / GenomeWeb Daily News - Researchers ID Colorectal Cancer Subtypes through Expression Profiling; Prognostic Value Noted
May 22, 2013 / GenomeWeb Daily News - At Investor Confab, Illumina Details 'Enormous' DTC Demand as Market Shifts to Less Complex Chips
May 21, 2013 / BioArray News